ABSTRACT
This chapter explains a case study of Boehringer Ingelheim that provides practical insights into the art of thriving as a global business. The family-owned Boehringer Ingelheim is one of leading pharmaceutical companies in the world. The company was founded in 1885 by Albert Boehringer in Ingelheim am Rhein. An important milestone occurred in 1948, when the first foreign subsidiary, Bender & Co. GmbH in Vienna, was established followed by various additional subsidiaries in Europe and overseas. Boehringer Ingelheim focuses on the therapeutic areas, research and development, and manufacturing and marketing of medications for human and veterinary medicine. Boehringer Ingelheim's business activities are organized on an industry sector basis, which is divided into five business units: prescription medicines; consumer healthcare; animal health; biopharmaceuticals; and industrial customers. Boehringer Ingelheim's activities can be also divided by geographical sales regions. The three largest sales markets for Boehringer Ingelheim are USA, Japan, and Germany, which generate approximately 57 percent of the total sales in 2015.
